Create a narrative

Bonesupport Holding Community

OM:BONEX Community

1 Narratives written by author
0 Comments on narratives written by author
29 Fair Values set on narratives written by author

Bonesupport Holding

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

FDA Submission And US Launch Will Drive Success

Key Takeaways High repeat usage and indication expansion in the U.S. drive strong growth for CERAMENT G, enhancing future revenue prospects and market share. Upcoming FDA approvals and reimbursement adjustments, alongside strategic marketing investments, are expected to boost revenue and margins across underpenetrated markets.

SEK 421.20

FV

29.7% undervalued

33.32%

Revenue growth p.a.

0

0

17

9 days ago